An analysis of the 2025 AHA/ACC hypertension guidelines found that under the new guidelines, about 11% of adults ages 65 to 79 with stage I hypertension would no longer qualify for blood pressure ...

The alternative text for this image may have been generated using AI. This Primer focuses on all forms of pulmonary hypertension from a global perspective and regardless of the underlying aetiology.

A new guideline to diagnose and treat hypertension is aimed at helping primary care clinicians, including family physicians, nurses, nurse practitioners, and pharmacists, manage the disease. The new ...

Sky Labs' ring-type cuffless BP monitor is the first of its kind to be integrated into the revised Korean Society of ...

The latest developments in the field of hypertension have led to a better understanding of the pathophysiology of hypertension as well as to new pharmacological and device-based therapies and a wealth ...

As more adults develop hypertension at younger ages, with many never reaching recommended treatment goals, updated clinical recommendations are changing how clinicians diagnose, monitor, and manage ...

A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without ...

Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...

Anumana has received 510(k) clearance from the US Food and Drug Administration (FDA) for its ECG-AI pulmonary hypertension (PH) detection algorithm, a software-as-a-medical-device (SaMD). The ...